Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

​ Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) – Relapsing-remitting

Interventions: Drug: Ublituximab

Sponsors: Northwestern University; TG Therapeutics, Inc.

Not yet recruiting Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) – Relapsing-remitting
Interventions: Drug: Ublituximab
Sponsors: Northwestern University; TG Therapeutics, Inc.
Not yet recruiting